What capital raising? Geez you don’t give up do you ….
You have failed to demonstrate anywhere that LTR have stated any intention of a “capital raising”.
You have failed to take consideration of the many alternative paths to capex satisfaction.
You have failed to respond to your true intentions here asking these questions.
You chose to attempt to put words in mouths of other members.
You choose to not respond to reasonable questions, which if you could/would respond to *might* improve the possible credence of your suggestions here.
Simple prepayment for spod by existing offtakes or sale of additional capacity now possible would give the minimal amount likely to be needed here after accounting for likely DSO income … so exactly why would LTR offer a competitor (ALB) equity to help “fund”??? You’ve failed to respond to why those avenues would be reasonable also.
Again … what capital raising are you banging on about? Soon your posts will simply have to be removed for unsubstantiated information reasons.
- Forums
- ASX - By Stock
- LTR
- Ann: Appointment of Chief Financial Officer
Ann: Appointment of Chief Financial Officer, page-75
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LTR (ASX) to my watchlist
|
|||||
Last
97.0¢ |
Change
-0.030(3.00%) |
Mkt cap ! $2.352B |
Open | High | Low | Value | Volume |
$1.03 | $1.03 | 96.5¢ | $13.68M | 13.82M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 76446 | 96.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
97.5¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 54268 | 0.965 |
16 | 448006 | 0.960 |
10 | 273881 | 0.955 |
34 | 357765 | 0.950 |
7 | 148508 | 0.945 |
Price($) | Vol. | No. |
---|---|---|
0.975 | 50000 | 1 |
0.980 | 30256 | 2 |
0.985 | 5873 | 2 |
0.990 | 28958 | 4 |
0.995 | 8676 | 3 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
LTR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online